United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-3202_0e469bdd-2787-4583-af53-18ddfff7a079
- Product NDC
- 50090-3202
- Form
- CAPSULE
- Composition / generic term
- Cephalexin
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110120
- Source listing expiry
- 20261231
Source-listed ingredients
- CEPHALEXIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 CAPSULE in 1 BOTTLE (50090-3202-0) · 50090-3202-0
- 14 CAPSULE in 1 BOTTLE (50090-3202-1) · 50090-3202-1
- 20 CAPSULE in 1 BOTTLE (50090-3202-2) · 50090-3202-2
- 28 CAPSULE in 1 BOTTLE (50090-3202-3) · 50090-3202-3
- 40 CAPSULE in 1 BOTTLE (50090-3202-4) · 50090-3202-4
- 30 CAPSULE in 1 BOTTLE (50090-3202-5) · 50090-3202-5
- 8 CAPSULE in 1 BOTTLE (50090-3202-6) · 50090-3202-6
- 16 CAPSULE in 1 BOTTLE (50090-3202-7) · 50090-3202-7
- 4 CAPSULE in 1 BOTTLE (50090-3202-8) · 50090-3202-8
- 12 CAPSULE in 1 BOTTLE (50090-3202-9) · 50090-3202-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →